Last edition
News about "EMA Approval "
EMA Accepts Bexsero Label Update for Meningitis B Booster
The European Medicines Agency (EMA) has accepted a label update for Bexsero that could enable a single booster dose to protect individuals aged 10 years and older previously vaccinated against Meningitis B.
EMA Approval | 21/07/2026 | By News Bureau | 104
Lupin Secures EMA Approval for Expanded NaMuscla Pediatric Use
Lupin has received EMA approval to expand the pediatric indication of NaMuscla, including two new capsule strengths of 62 mg and 83 mg.
EMA Approval | 03/07/2026 | By News Bureau | 341
Eisai and Nuvation Bio Secure EMA Validation for Taletrectinib in Lung Cancer
EU regulator begins review of next-generation targeted therapy for advanced ROS1-positive non-small cell lung cancer.
EMA Approval | 30/03/2026 | By News Bureau | 229
Duke Street Bio Gets EMA Approval to Launch PARP1-Selective Inhibitor Trial
This potentially best-in-class, potent, highly selective and CNS-penetrant agent targets cancers that harbour homologous recombination deficiencies (HRD) including BRCA mutations.
EMA Approval | 25/09/2024 | By Aishwarya | 812
Biocon Biologics Gets EMA Approval for Bevacizumab and its New mAbs Facility in India
Biocon Biologics Ltd. has received approval from the European Medicines Agency (EMA) to manufacture biosimilar Bevacizumab at its new, world-class, multi-product monoclonal antibodies (mAbs) drug substance facility in Bengaluru.
EMA Approval | 24/06/2024 | By Aishwarya | 1271
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy